TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

TransMedics Group, Inc.

Cash

Cash %Chg

Cash Common Size

Marketable Securities

Marketable Securities %Chg

Marketable Securities Common Size

Accounts Receivable

Accounts Receivable %Chg

Accounts Receivable Common Size

Inventory

Inventory %Chg

Inventory Common Size

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets %Chg

Prepaid Expenses and Other Current Assets Common Size

Total Current Assets

Total Current Assets %Chg

Total Current Assets Common Size

Property, Plant and Equipment, Net

Property, Plant and Equipment, Net %Chg

Property, Plant and Equipment, Net Common Size

Deferred Offering Costs

Deferred Offering Costs %Chg

Deferred Offering Costs Common Size

Operating Lease Right-of-Use Assets

Operating Lease Right-of-Use Assets %Chg

Operating Lease Right-of-Use Assets Common Size

Restricted Cash

Restricted Cash %Chg

Restricted Cash Common Size

Goodwill

Goodwill %Chg

Goodwill Common Size

Acquired Intangible Assets, Net

Acquired Intangible Assets, Net %Chg

Acquired Intangible Assets, Net Common Size

Other Non-Current Assets

Other Non-Current Assets %Chg

Other Non-Current Assets Common Size

Total Assets

Total Assets %Chg

Total Assets Common Size

Accounts Payable

Accounts Payable %Chg

Accounts Payable Common Size

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities %Chg

Accrued Expenses and Other Current Liabilities Common Size

Deferred Revenue

Deferred Revenue %Chg

Deferred Revenue Common Size

Operating Lease Liabilities

Operating Lease Liabilities %Chg

Operating Lease Liabilities Common Size

Total Current Liabilities

Total Current Liabilities %Chg

Total Current Liabilities Common Size

Preferred Stock Warrant Liability

Preferred Stock Warrant Liability %Chg

Preferred Stock Warrant Liability Common Size

Convertible Senior Notes, Net

Convertible Senior Notes, Net %Chg

Convertible Senior Notes, Net Common Size

Long-Term Debt, Net

Long-Term Debt, Net %Chg

Long-Term Debt, Net Common Size

Operating Lease Liabilities, Net of Current Portion

Operating Lease Liabilities, Net of Current Portion %Chg

Operating Lease Liabilities, Net of Current Portion Common Size

Deferred Rent, Net of Current Portion

Deferred Rent, Net of Current Portion %Chg

Deferred Rent, Net of Current Portion Common Size

Total Liabilities

Total Liabilities %Chg

Total Liabilities Common Size

Convertible Preferred Stock (Series a-1, B, B-1, C, D, E and F) $0.0001 Par Value

Convertible Preferred Stock (Series a-1, B, B-1, C, D, E and F) $0.0001 Par Value %Chg

Convertible Preferred Stock (Series a-1, B, B-1, C, D, E and F) $0.0001 Par Value Common Size

Common Stock

Common Stock %Chg

Common Stock Common Size

Additional Paid-in Capital

Additional Paid-in Capital %Chg

Additional Paid-in Capital Common Size

Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income %Chg

Accumulated Other Comprehensive Income Common Size

Retained Earnings

Retained Earnings %Chg

Retained Earnings Common Size

Total Stockholders' Equity

Total Stockholders' Equity %Chg

Total Stockholders' Equity Common Size

Total Liabilities and Stockholders' Equity

Total Liabilities and Stockholders' Equity %Chg

Total Liabilities and Stockholders' Equity Common Size

Cash and Cash Equivalents

Cash and Cash Equivalents %Chg

Cash and Cash Equivalents Common Size

Short-Term Investments

Short-Term Investments %Chg

Short-Term Investments Common Size

Total Cash and Cash Equivalents

Total Cash and Cash Equivalents %Chg

Total Cash and Cash Equivalents Common Size

Total Trade Receivables

Total Trade Receivables %Chg

Total Trade Receivables Common Size

Inventories

Inventories %Chg

Inventories Common Size

Other Current Assets

Other Current Assets %Chg

Other Current Assets Common Size

Net Property, Plant & Equipment

Net Property, Plant & Equipment %Chg

Net Property, Plant & Equipment Common Size

Net Intangible Assets

Net Intangible Assets %Chg

Net Intangible Assets Common Size

Other Long-Term Assets

Other Long-Term Assets %Chg

Other Long-Term Assets Common Size

Accrued Expenses

Accrued Expenses %Chg

Accrued Expenses Common Size

Current Portion of Leases

Current Portion of Leases %Chg

Current Portion of Leases Common Size

Unearned Revenue

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Assets	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Cash and Cash Equivalents	400.6	336.7	362.8	394.8	582.2	201.2
Cash
Short-Term Investments	—	—	—	—	—	—
Marketable Securities
Total Cash and Cash Equivalents	400.6	336.7	362.8	394.8	582.2	201.2
Accounts Receivable	104.9	97.7	81.2	63.6	47.5	27.6
Accounts Receivable
Total Trade Receivables	104.9	97.7	81.2	63.6	47.5	27.6
Inventories	38.9	46.6	48.7	44.2	30.5	20.6
Inventory
Other Current Assets	14.3	16.8	17.2	8.5	3.1	3.4
Prepaid Expenses and Other Current Assets
Restricted Cash
Total Current Assets	558.1	497.2	509.3	510.7	662.7	252.3
Total Current Assets
Net Property, Plant & Equipment	318.1	292.5	234.9	180.5	26.9	24.4
Property, Plant and Equipment, Net
Operating Lease Right-of-Use Assets
Net Intangible Assets	2.1	2.2	2.3	2.4	—	—
Acquired Intangible Assets, Net
Goodwill	11.5	11.5	11.5	12	—	—
Goodwill
Other Long-Term Assets	0.2	0.2	0.1	0.1	0.1	—
Deferred Offering Costs
Other Non-Current Assets
Total Assets	890.5	804.1	758.6	706	690.4	277.1
Total Assets

Liabilities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Accounts Payable	9.5	10.3	13	12.7	7	3.3
Accounts Payable
Accrued Expenses	42.5	45.2	37.7	38.2	22.9	18.6
Accrued Expenses and Other Current Liabilities
Current Portion of Leases	3	2.7	2.1	2	1.9	1.4
Operating Lease Liabilities
Unearned Revenue	1.6	1.7	1.4	2	0.2	0.2
Deferred Revenue
Other Current Liabilities	42.5	45.2	37.7	38.2	22.9	18.6
Accrued Expenses and Other Current Liabilities
Total Current Liabilities	56.6	59.9	54.3	54.9	32	23.7
Total Current Liabilities
Long-Term Debt	510.9	509.3	507.8	506.2	504.7	58.7
Convertible Senior Notes, Net
Long-Term Debt, Net
Leases	4.9	6.2	6.6	7.7	8.5	7.4
Operating Lease Liabilities, Net of Current Portion
Other Long-Term Liabilities	—	—	—	—	—	—
Preferred Stock Warrant Liability
Deferred Rent, Net of Current Portion
Total Long-Term Liabilities	515.8	515.6	514.4	513.9	513.1	66.1
Total Liabilities	572.4	575.5	568.7	568.8	545.1	89.8
Total Liabilities

Equity	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Preferred Stock	—	—	—	—	—	—
Convertible Preferred Stock (Series a-1, B, B-1, C, D, E and F) $0.0001 Par Value
Common Stock	725.7	697.2	669.4	641.1	627.7	666.3
Common Stock
Common Stock
Additional Paid-in Capital	—	—	—	—	—	—
Additional Paid-in Capital
Accumulated Other Comprehensive Income	0.1	-0.4	-0.2	-0.2	-0.2	-0.2
Accumulated Other Comprehensive Income
Retained Earnings	-407.7	-468.2	-479.3	-503.7	-482.3	-478.7
Retained Earnings
Total Common Shareholders' Equity	318.1	228.6	189.9	137.2	145.2	187.4
Total Stockholders' Equity
Total Shareholders' Equity	318.1	228.6	189.9	137.2	145.2	187.4
Total Liabilities and Shareholders' Equity	890.5	804.1	758.6	706	690.4	277.1
Total Liabilities and Stockholders' Equity